September 18, 2008

Excerpta Medica Helps Pharma Companies Fulfill 2009 Pharma Guidelines With Elsevier’s Physician and Patient Educational Content

NEW YORK, Sept. 18 /PRNewswire/ -- Excerpta Medica, an Elsevier company providing strategic medical communications, announced today that it will offer pharmaceutical and biotechnology companies new medically relevant products customized from various well-known Elsevier brands developed in response to recent changes made in the Pharmaceutical Research and Manufacturers Association's code on interactions with healthcare providers. Slated to go into effect in January 2009, the code recommends physician-mediated patient education over more traditional approaches such as meeting sponsorships, promotional giveaways or meals.

(Logo: )

Elsevier is the world's leading publisher of scientific, technical and medical information products and services. Its highly respected medical brands include Gray's Anatomy, MD Consult and The Atlas of Human Anatomy by Frank H. Netter, MD.

"The most recent changes in the PhRMA code reinforce Elsevier's mission to support physicians with the kind of information and education they can trust and enthusiastically share with their patients," says Greg Samios, President of Excerpta Medica. "By delivering the right information to the right physician at the right time, these products will help physicians change patients' attitudes, beliefs and behaviors."

Excerpta Medica's educational products cover a wide variety of timely health and medical topics and therapeutic areas -- from primary care and cardiology to oncology, rheumatology and respiratory diseases to name a few. Educational media include handheld pocket educators, 3-D models, flash cards, flip and wall charts, patient handouts and checklists, plus interactive and web-based programs, including iPod(R) and iPhone(R) offerings. For example, physicians can educate patients with migraines about their causes and provide tips on preventing them with Elsevier's "Migraine" Netter wall chart and supporting print and electronic materials.

In addition to benefiting from Elsevier's experience in health and medical publishing, pharmaceutical companies will appreciate Excerpta Medica's ability to customize and brand physician and patient educational materials while meeting the needs of just about any physician practice -- no matter what its size, specialty or location -- while still being fully PhRMA compliant.

For more information contact Julie Artim of Excerpta Medica at [email protected] or 908-547-2094, or visit

About Excerpta Medica

Excerpta Medica, an Elsevier business, is a global communications company servicing health care clients in the areas of medical education, medical communications, publication planning and interactive solutions. Excerpta Medica's experienced team of professionals with expertise in pharmaceuticals, health care, and medical publishing work to deliver scientific and creative solutions to suit our clients needs. Excerpta Medica ( has offices in the US (Bridgewater, NJ), Canada (Toronto), and The Netherlands (Amsterdam).

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Photo: Archive: Photo Desk, [email protected]

Excerpta Medica

CONTACT: Tom Reller, Director, Corporate Relations of Excerpta Medica,+1-212-462-1912, [email protected]

Web site: